There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (3)

Short Titles

Short Titles - House of Representatives

Short Title(s) as Introduced

AARF Act of 2021
Alternatives to Animals for Regulatory Fairness Act of 2021

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend the Federal Food, Drug, and Cosmetic Act to allow the sponsor of a drug to use a non-animal test as an alternative to an animal test for purposes of demonstrating the safety and effectiveness of a drug if such approach satisfies the requirements of the applicable statutes and regulations.


Actions Overview (1)

Date Actions Overview
03/16/2021Introduced in House

All Actions (2)

Date All Actions
03/16/2021Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
03/16/2021Introduced in House
Action By: House of Representatives

Cosponsors (16)


Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Related Documents
House Energy and Commerce03/16/2021 Referred to

As of 06/13/2021 no related bill information has been received for H.R.1905 - AARF Act of 2021


Subjects (4)


Latest Summary (1)

There is one summary for H.R.1905. View summaries

Shown Here:
Introduced in House (03/16/2021)

Animals for Regulatory Fairness Act of 2021 or the AARF Act of 2021

This bill requires the Food and Drug Administration to allow an applicant for approval to market a new drug to use a non-animal test to demonstrate the safety and effectiveness of the drug if the non-animal test satisfies all other applicable requirements.